Compare ZENITH HEALTH with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZENITH HEALTH vs ALKEM LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZENITH HEALTH ALKEM LABORATORIES ZENITH HEALTH/
ALKEM LABORATORIES
 
P/E (TTM) x 118.9 23.9 497.8% View Chart
P/BV x 6.8 5.7 119.7% View Chart
Dividend Yield % 0.0 0.9 -  

Financials

 ZENITH HEALTH   ALKEM LABORATORIES
EQUITY SHARE DATA
    ZENITH HEALTH
Mar-21
ALKEM LABORATORIES
Mar-21
ZENITH HEALTH/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs153,150 0.5%   
Low Rs12,224 0.0%   
Sales per share (Unadj.) Rs2.6741.4 0.3%  
Earnings per share (Unadj.) Rs0.1135.3 0.1%  
Cash flow per share (Unadj.) Rs0.1158.3 0.1%  
Dividends per share (Unadj.) Rs030.00 0.0%  
Avg Dividend yield %01.1 0.0%  
Book value per share (Unadj.) Rs1.3616.8 0.2%  
Shares outstanding (eoy) m53.74119.57 44.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x3.23.6 87.8%   
Avg P/E ratio x99.419.9 500.4%  
P/CF ratio (eoy) x63.317.0 373.1%  
Price / Book Value ratio x6.44.4 146.7%  
Dividend payout %022.2 0.0%   
Avg Mkt Cap Rs m437321,244 0.1%   
No. of employees `000NANA-   
Total wages/salary Rs m1116,210 0.1%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m13788,650 0.2%  
Other income Rs m52,332 0.2%   
Total revenues Rs m14290,982 0.2%   
Gross profit Rs m419,424 0.0%  
Depreciation Rs m32,746 0.1%   
Interest Rs m0589 0.0%   
Profit before tax Rs m618,421 0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m12,243 0.1%   
Profit after tax Rs m416,178 0.0%  
Gross profit margin %2.621.9 11.9%  
Effective tax rate %21.212.2 173.9%   
Net profit margin %3.218.2 17.5%  
BALANCE SHEET DATA
Current assets Rs m6469,288 0.1%   
Current liabilities Rs m1936,041 0.1%   
Net working cap to sales %32.437.5 86.5%  
Current ratio x3.31.9 172.5%  
Inventory Days Days720 35.9%  
Debtors Days Days44,857,99066 67,788,113.6%  
Net fixed assets Rs m2134,825 0.1%   
Share capital Rs m54239 22.5%   
"Free" reserves Rs m1573,517 0.0%   
Net worth Rs m6873,756 0.1%   
Long term debt Rs m0343 0.0%   
Total assets Rs m84104,114 0.1%  
Interest coverage x51.732.3 160.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.60.9 191.1%   
Return on assets %5.316.1 33.2%  
Return on equity %6.421.9 29.3%  
Return on capital %8.325.7 32.4%  
Exports to sales %022.1 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA19,555 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m7319,555 0.4%   
Fx outflow Rs m12,467 0.0%   
Net fx Rs m7217,088 0.4%   
CASH FLOW
From Operations Rs m-1512,649 -0.1%  
From Investments Rs m-2-9,985 0.0%  
From Financial Activity Rs mNA-2,718 0.0%  
Net Cashflow Rs m-17-17 96.0%  

Share Holding

Indian Promoters % 28.7 57.1 50.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.4 19.3 2.0%  
FIIs % 0.0 5.4 -  
ADR/GDR % 0.0 0.0 -  
Free float % 71.3 42.9 166.2%  
Shareholders   32,818 86,881 37.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZENITH HEALTH With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

5 Reasons Why Sensex Crashed 1,546 Points Today(Closing)

Indian share markets witnessed heavy selling pressure today and ended deep in the red. The sell-off continued for the fifth straight session today with benchmark indices losing nearly 3% each.

Related Views on News

ALKEM LABORATORIES Announces Quarterly Results (1QFY22); Net Profit Up 13.5% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, ALKEM LABORATORIES has posted a net profit of Rs 5 bn (up 13.5% YoY). Sales on the other hand came in at Rs 27 bn (up 37.1% YoY). Read on for a complete analysis of ALKEM LABORATORIES's quarterly results.

ALKEM LABORATORIES 2020-21 Annual Report Analysis (Annual Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

Here's an analysis of the annual report of ALKEM LABORATORIES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of ALKEM LABORATORIES. Also includes updates on the valuation of ALKEM LABORATORIES.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

More Views on News

Most Popular

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ZENITH HEALTH SHARE PRICE


Jan 24, 2022 (Close)

TRACK ZENITH HEALTH

  • Track your investment in ZENITH HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ZENITH HEALTH 5-YR ANALYSIS

COMPARE ZENITH HEALTH WITH

MARKET STATS